Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions

Clinical Nephrology

Volumn 46, Issue 4, 1996, Pages 237-244

  Faedda, R ^a   Pirisi, M ^b   Satta, A ^a   Tanda, F ^a   Bartoli, E ^b,c  

^a UNIVERSITY OF SASSARI   (Italy)

^b Ospedale di Careggi   (Italy)

^c Università degli Studi   (Italy)

Author keywords

Chronic renal failure; Cyclophosphamide; Immunosuppression; Mesangial proliferation; Mesangial sclerosis; Nephrotic syndrome; Prednisone; Proteinuria

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG EFFICACY; FEMALE; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; HISTOLOGY; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIUM; NEPHROTIC SYNDROME; ORAL DRUG ADMINISTRATION; PROTEINURIA; REMISSION;

EID: 0029807399     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Appel GB, Blum CB, Chien S, Kunis CL, Appel AS 1985 The hyperlipidemia of the nephrotic syndrome: relation to plasma albumin concentration, oncotic pressure and viscosity. N Engl J Med 312: 1544
2. Berns JS, Gaudio KM, Krassner LS, Anderson FP, Durante D, Mc Donald DM, Siegel NJ 1987 Steroid-responsive nephrotic syndrome of childhood: a long term study of clinical course, histopathology, efficacy of cyclophosphamide therapy and effects on growth. Am J Kidney Dis 9: 108
3. Blayney DW, Longo DL, Young RC, Greene ME, Hubbard SM, Postal MG, Duffey PL, De Vita VT Jr 1987 Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N Engl J Med 316: 710
4. Bruns FS, Adler S, Fraley DS, Segel DP 1991 Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone. Ann Int Med 114: 725
5. Burkholder PM, Marchand A, Krueger RP 1970 Mixed membranous and proliferative glomerulonephritis. A correlative light, immunofluorescence and electron microscopy. Lab Invest 23: 459
6. Cattran DC, Cardella CJ, Roscoe JM, Charron RC, Rance PC, Ritchie SM, Corey PN 1985 Results of a controlled drug trial in membranoproliferative glomerulonephritis. Kidney Int 27: 436
7. Davison AM, Cameron JS, Kerr DSN, Oggs CS, Wilkinson RW 1984 The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol 22: 61
8. Earley LE, Forland M 1979 Nephrotic syndrome. In: Early LE, Gottschalk CW (eds) Strauss and Welt's Diseases of the Kidney. Little, Brown and Co., Boston, p 765
9. Faedda R, Satta A, Bosincu L, Pirisi M, Bartoli E 1995 Immunosuppressive treatment of membranous glomerulonephritis. J Nephrol 8: 107
10. Faedda R, Satta A, Tanda F, Pirisi M, Bartoli E 1994 Immunosuppressive treatment of membrano-proliferative glomerulonephritis. Nephron 67: 59
11. Glassock RJ, Adler SG, Ward HJ, Cohen AH 1991 Primary glomerular diseases. In: Brenner BM, Rector FC Jr (eds) The Kidney. 4th edn., WB Saunders Co., Philadelphia, p 1182
12. Griswold WR, Tune BM, Reznik VM, Vazquez M, Prime DJ, Brock P, Mendoza SA 1987 Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents. Nephron 46: 73
13. Levey S, Lau J, Pauker SG, Kassirer JP 1987 Idiopathic Nephrotic Syndrome. Ann Int Med 107: 697
14. Mc Cluskey RT, Vassalli P, Gallo G, Baldwin DS 1966 An immunofluorescent study of pathogenetic mechanism in glomerular diseases. N Engl J Med 274: 695
15. Noble B, Steward MW, Vladutiu A, Brentjens JR 1987 Relationship of the quality and quantity of circulating anti-BSA antibodies to the severity of glomerulonephritis in rats with chronic serum sickness. Clin Exp Immunol 67: 277
16. Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Radaelli B, Sasdelli M, Locatelli F 1989 A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 320: 8
17. Portlock CS, Rosenberg SA 1979 No initial therapy for stage III and IV non-Hodgkin lymphomas of favorable histologic types. Ann Int Med 90: 10
18. Rodriguez MA, Fuller LM, Zimmerman SO, Allen PK, Brown BW, Munsell MF, Hagemeister FB, McLaughlin P, Velasquez WS, Swan F Jr, Cabanillas FF 1993 Hodgkin's disease: study of treatment intensities and incidence of second malignancies. Ann Oncol 4: 125
19. Rohwedder HJ, Volzke E 1963 Nephrotic syndrome after small-pox vaccination. Arch Kinderheilk 168: 53
20. Wakai S, Magil AB 1992 Focal glomerulosclerosis in idiopathic membranous glomerulonephritis. Kidney Int 41: 428
21. Wilson CR 1991 The renal response to immunologic injury. In: Brenner BM, Rector FC Jr (eds) The Kidney. 4th edn., WB Saunders Co., Philadelphia, p 1062